BactoSight™ is a software as a medical device designed to estimate bacteremia risk using routinely collected EHR data in eligible adults (18-80) with suspected bacteremia, after a blood culture is ordered.
Routine clinical data
Uses vital signs, CBC, CMP, and other available EHR data
Clear risk information
Provides a risk score and one of five risk categories
Additional clinical context
Designed to support interpretation alongside other available clinical information
Supporting antibiotic management
Offers timely bacteremia risk insights to support clinicians' review of antibiotic therapy alongside other clinical findings
Very low risk NPV
Low risk NPV
Observed in our validation dataset. Predictive values depend on the popluation.
BactoSight™ supplements clinician judgment and is not intended as the sole basis for diagnosis, treatment, or disposition decisions.
We are connecting with hospitals and health systems interested in evaluating BactoSight in real-world clinical workflows.
Workflow fit and clinical decision timing
Clinician experience and adoption
EHR integration and potential operational value
To get started, please fill out the form.
